STUB1 and cardiovascular disorder: There was no significant association between TP53-CHIP and cardiovascular disease mortality [Fig. 2A; HR, 1.22; 95% CI, 0.95–1.56; P (Wald test) = 0.117] or with specific types of cardiovascular disease (Fig. 2B).